CPMD OTC
CannaPharmaRX, Inc.
1W: +0.0%
1M: -16.7%
3M: -16.7%
YTD: -77.3%
1Y: -33.3%
3Y: -80.0%
5Y: -94.3%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±8.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$820K
+0.0% ▲
Gross Profit
-$3M
-4376.7% ▼
Operating Income
-$4M
-128.1% ▼
Net Income
-$10M
-368.6% ▼
EPS (Diluted)
$-0.02
-232.8% ▼
EBITDA
-$8M
-428.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $820K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $129K | $14K | $295K | $66K | $4M |
| Gross Profit | -$129K | -$14K | -$295K | -$66K | -$3M |
| Gross Margin | — | — | — | — | -357.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5M | $3M | $5M | $1M | $598K |
| Operating Expenses | $5M | $3M | $5M | $2M | $671K |
| Operating Income | -$14M | -$3M | -$5M | -$2M | -$4M |
| Operating Margin | — | — | — | — | -439.7% |
| Interest Expense | $2M | $2M | $2M | $2M | $2M |
| Income Before Tax | -$20M | -$9M | -$9M | $4M | -$10M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20M | -$9M | -$9M | $4M | -$10M |
| Net Margin | — | — | — | — | -1207.8% |
| EPS (Diluted) | $-0.49 | $-0.12 | $-0.04 | $0.01 | $-0.02 |
| EBITDA | -$17M | -$3M | -$5M | -$1M | -$8M |
| Shares Outstanding | 41M | 75M | 211M | 309M | 625M |